On October 1, 2026, DocGo Inc. and its subsidiaries entered into an Amended and Restated Credit Agreement and Guaranty. This agreement amends and restates a credit facility originally dated December 6, 2022. The new agreement establishes a total credit facility of $102 million, comprised of four term loan facilities.

The first facility, Term Loan A, continues existing debt with an outstanding principal amount of $52 million. Term Loan B is a new facility in the amount of $12.5 million, which is to be funded on the effective date of the agreement. Term Loan C is another new facility in the amount of $12.5 million, which will be funded upon the consummation of a pending merger. Finally, Term Loan D is a delayed draw facility in the amount of $25 million, available between the closing date of the merger and December 31, 2027.

The term loans bear interest at a rate per annum equal to Term SOFR, subject to a floor of 3.50%, plus an applicable margin of 7.50%. The entire outstanding principal amount, including accrued interest, is due and payable on the Stated Maturity Date of December 6, 2029. The agreement includes customary financial covenants, events of default, and negative covenants restricting the borrowers from incurring additional indebtedness, creating liens, or making certain investments and restricted payments.

In connection with the agreement, DocGo also entered into an Amended and Restated Security Agreement. This agreement grants the Administrative Agent a first-priority security interest in substantially all of the grantors' personal property, including accounts, equipment, and intellectual property, to secure the obligations under the credit agreement.

Additionally, the company issued a warrant to the Administrative Agent to purchase up to 4,000,000 shares of its common stock at an exercise price of $0.5039 per share. The warrant is fully vested and may be exercised at any time prior to the tenth anniversary of the issue date, subject to specific conditions regarding liquidity events and acquisitions. The warrant was issued without underwriting discounts or commissions and was issued pursuant to an exemption from registration requirements under the Securities Act of 1933.

Separately, on October 1, 2026, the company terminated its existing revolving credit facility dated August 7, 2025, with Citibank, N.A., which had not been drawn at the time of termination.